HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by García-Burillo, A. Articles by Bosch, J.-A. Search for Related Content PubMed PubMed Citation Articles by García-Burillo, A. Articles by Bosch, J.-A.

Technetium-99m-HMPAO Brain SPECT in Brain Spectin Behçet's Disease

Departments of Nuclear Medicine and Internal Medicine, Hospital General Universitari Vall d'Hebron, Barcelona, Spain

Correspondence: For correspondence or reprints contact: Amparo García-Burillo, MD, Nuclear Medicine Department, Hospital General Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

ABSTRACT

Behçet's disease (BD) is an idiopathic multisystem disorder. Involvement of the central nervous system (CNS) occurs in 4%–48% of cases. The aim of this study was to evaluate ^99mTc-hexamethyl propyleneamine oxime (HMPAO) SPECT findings in BD patients and eventuallyto detect CNS involvement by depicting cerebral blood flow disturbances. Methods: Technetium-99m-HMPAO brain SPECT was performed on 33 consecutive BD palients. Qualitative and quantitative evaluation of the cortical uptake was done using an automatic program that generated 32 regions of interest (ROIs). An uptake index for each ROI was Obtained. Reference values were obtained from a healthy control group (n = 20). Twenty-five patients also had an MRI study. Results: Twelve of 32 patients (36%) presented with a clinical neurological disorder. SPECT and visual evaluation revealed that 17 patients (51.5%) had abnormalities; 9 of 25 MRI studies (36%) were abnormal. Using the quantitative approach for SPECT, 23 patients (69.7%) had abnormally low values. Six of 12 patients with neurological symptoms had a visually abnormal SPECT scan, whereas quantitative analysis showed abnormalities in 11 patients. Of the 21 patients with no neurological findings, 9 had abnormal SPECT results, and 12 had low uptake indexes. Conclusion: HMPAO brain SPECT shows high rates of cerebral blood flow abnormalities in BD patients presenting with neuropsychiatric symptoms and it also is frequently abnormal in asymptomatic BD patients who have no abnormalities on MR scans. Compared with visual analysis, quantitative analysis detects an even higher rate of SPECT changes in BD patients.

Key Words: Behçet's disease • SPECT • regional cerebral bloodflow • technetium-99m-hexamethyl propyleneamine oxime

This article has been cited by other articles:

				S. Vignola, F. Nobili, P. Picco, M. Gattorno, A. Buoncompagni, P. Vitali, G. Mariani, and G. Rodriguez Brain Perfusion SPECT in Juvenile Neuro-Behcet's Disease J. Nucl. Med., August 1, 2001; 42(8): 1151 - 1157. [Abstract] [Full Text] [PDF]